| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = -$105,902 ) |
| | 2024 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 000 | 4 | NIH | 1/10/2024 | -$105,902 |
| | 2024 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 000 | 4 | NIH | 6/26/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = -$29,293 ) |
| | 2023 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES031787 | Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats | 000 | 2 | NIH | 5/31/2023 | -$83,997 |
| | 2023 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA193532 | Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy | 000 | 5 | NIH | 5/15/2023 | $0 |
| | 2023 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES029448 | Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure | 000 | 3 | NIH | 5/18/2023 | -$58,064 |
| | 2023 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL068111 | Resolution of Epithelial Cell Hyperplasia in Asthma | 000 | 15 | NIH | 4/27/2023 | $112,768 |
|
| Issue Date FY: 2022 ( Subtotal = -$300,522 ) |
| | 2022 | 2022 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 000 | 5 | NIH | 8/1/2022 | $249,000 |
| | 2022 | 2022 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 001 | 5 | NIH | 8/26/2022 | -$249,000 |
| | 2022 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 001 | 4 | NIH | 8/26/2022 | -$291,258 |
| | 2022 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES031787 | Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats | 001 | 2 | NIH | 6/2/2022 | $0 |
| | 2022 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA193532 | Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy | 000 | 5 | NIH | 7/7/2022 | -$9,235 |
| | 2022 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DE026013 | Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium | 000 | 4 | NIH | 9/28/2022 | $0 |
| | 2022 | 2018 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL140839 | Wood Smoke and Chronic Mucous Hypersecretion | 000 | 1 | NIH | 6/29/2022 | -$65 |
| | 2022 | 2017 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL125000 | HIV-associated Chronic Obstructive Pulmonary Disease | 000 | 4 | NIH | 9/26/2022 | $36 |
| | 2022 | 2016 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R21AI115291 | Bik Promotes Cleavage of Viral Proteins to Enhance Influenza A Virus Infection | 000 | 2 | NIH | 10/1/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = -$798,097 ) |
| | 2021 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 000 | 4 | NIH | 8/13/2021 | $449,013 |
| | 2021 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES031787 | Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats | 000 | 2 | NIH | 5/28/2021 | $652,940 |
| | 2021 | 2021 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 001 | 4 | NIH | 8/18/2021 | $249,000 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES029448 | Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure | 000 | 3 | NIH | 1/12/2021 | $0 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 003 | 3 | NIH | 5/20/2021 | -$56,346 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 004 | 3 | NIH | 5/20/2021 | -$139,205 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 000 | 3 | NIH | 3/24/2021 | -$627,764 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 000 | 3 | NIH | 3/24/2021 | -$148,240 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 000 | 3 | NIH | 2/23/2021 | $105,902 |
| | 2021 | 2020 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA196590 | Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy | 000 | 5 | NIH | 3/29/2021 | -$288,303 |
| | 2021 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R03CA223637 | The hexosamine biosynthesis pathway in human bronchial epithelial cell transformation. | 000 | 2 | NIH | 5/25/2021 | -$1,068 |
| | 2021 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 002 | 2 | NIH | 5/20/2021 | -$366,773 |
| | 2021 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01DE026013 | Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium | 000 | 4 | NIH | 2/26/2021 | $0 |
| | 2021 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA196590 | Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy | 003 | 4 | NIH | 8/2/2021 | -$625,895 |
| | 2021 | 2018 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA183296 | Histone Methyltransferases as a Target for Lung Cancer Prevention | 000 | 5 | NIH | 5/6/2021 | $0 |
| | 2021 | 2017 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL125000 | HIV-associated Chronic Obstructive Pulmonary Disease | 000 | 4 | NIH | 8/10/2021 | -$1,357 |
|
| Issue Date FY: 2020 ( Subtotal = $1,311,992 ) (Continued on the next page) |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA196590 | Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy | 000 | 5 | NIH | 7/1/2020 | $288,303 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R00DA047432 | Neural circuit control of mesolimbic dopamine and reward | 000 | 3 | NIH | 8/19/2020 | $249,000 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES031787 | Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats | 000 | 1 | NIH | 5/19/2020 | $660,000 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 004 | 3 | NIH | 6/9/2020 | $449,779 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 002 | 3 | NIH | 8/12/2020 | $139,205 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 001 | 3 | NIH | 8/10/2020 | $684,110 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 001 | 3 | NIH | 8/10/2020 | $148,240 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01ES029448 | Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure | 000 | 3 | NIH | 6/26/2020 | $638,624 |
| | 2020 | 2020 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01CA193532 | Aerosol Delivery of Topotecan for Personalized Lung Cancer Therapy | 000 | 5 | NIH | 2/26/2020 | $381,186 |
| | 2020 | 2019 | LOVELACE BIOMEDICAL AND ENVIRONMENTAL RESEARCH INSTITUTE, INC. | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 003 | 2 | NIH | 5/4/2020 | $16,480 |
| | 2020 | 2019 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01NS112808 | Brain Injury Treatment by Modulation of Hemodynamics with Blood Soluble Drag Reducing Molecules | 001 | 2 | NIH | 3/9/2020 | $291,062 |
| | 2020 | 2019 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 000 | 2 | NIH | 4/29/2020 | $0 |
| | 2020 | 2019 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | U01CA232505 | DNA Repair Capacity Assays for Lung Disease Risk Assessment | 000 | 2 | NIH | 4/29/2020 | $0 |
| | 2020 | 2019 | LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC | 2425 RIDGECREST DR SE | ALBUQUERQUE | NM | 87108-5129 | BERNALILLO | USA | R01HL140839 | Wood Smoke and Chronic Mucous Hypersecretion | 000 | 2 | NIH | 3/23/2020 | -$833,289 |
|
